Works matching IS 00223417 AND DT 2024 AND VI 263 AND IP 2

Results: 14

From morphology to methylome: epigenetic studies of Müllerian mesonephric‐like adenocarcinoma reveal similarities to cervical mesonephric adenocarcinoma†.
Published in:
Journal of Pathology, 2024, v. 263, n. 2, p. 135, doi. 10.1002/path.6285
By:
- Lin, Lawrence H;
- Howitt, Brooke E;
- Kolin, David L
Publication type:
Article
Acquired NF2 mutation confers resistance to TRK inhibition in an ex vivoLMNA::NTRK1‐rearranged soft‐tissue sarcoma cell model.
Published in:
Journal of Pathology, 2024, v. 263, n. 2, p. 257, doi. 10.1002/path.6282
By:
- Chen, Yanjiang;
- Steiner, Sabrina;
- Hagedorn, Catherine;
- Kollar, Sarah;
- Pliego‐Mendieta, Alicia;
- Haberecker, Martina;
- Plock, Jan;
- Britschgi, Christian;
- Planas‐Paz, Lara;
- Pauli, Chantal
Publication type:
Article
Correction to 'Autophagy mediates survival of pancreatic tumour‐initiating cells in a hypoxic microenvironment'.
Published in:
Journal of Pathology, 2024, v. 263, n. 2, p. 270, doi. 10.1002/path.6281
Publication type:
Article
Co‐targeting BET, CBP, and p300 inhibits neuroendocrine signalling in androgen receptor‐null prostate cancer.
Published in:
Journal of Pathology, 2024, v. 263, n. 2, p. 242, doi. 10.1002/path.6280
By:
- Choo, Nicholas;
- Keerthikumar, Shivakumar;
- Ramm, Susanne;
- Ashikari, Daisaku;
- Teng, Linda;
- Niranjan, Birunthi;
- Hedwards, Shelley;
- Porter, Laura H;
- Goode, David L;
- Simpson, Kaylene J;
- Taylor, Renea A;
- Risbridger, Gail P;
- Lawrence, Mitchell G
Publication type:
Article
Cell division‐dependent dissemination following E‐cadherin loss underlies initiation of diffuse‐type gastric cancer.
Published in:
Journal of Pathology, 2024, v. 263, n. 2, p. 226, doi. 10.1002/path.6277
By:
- Monster, Jooske L;
- Kemp, Lars JS;
- Busslinger, Georg A;
- Vliem, Marjolein J;
- Derks, Lucca LM;
- Staes, Annelot AL;
- Bisseling, Tanya M;
- Clevers, Hans;
- van der Post, Rachel S;
- Gloerich, Martijn
Publication type:
Article
Polyketide synthase positive Escherichia coli one‐time measurement in stool is not informative of colorectal cancer risk in a screening setting.
Published in:
Journal of Pathology, 2024, v. 263, n. 2, p. 217, doi. 10.1002/path.6276
By:
- de Klaver, Willemijn;
- de Wit, Meike;
- Bolijn, Anne;
- Tijssen, Marianne;
- Delis‐van Diemen, Pien;
- Lemmens, Margriet;
- Spaander, Manon CW;
- Dekker, Evelien;
- van Leerdam, Monique E;
- Coupé, Veerle MH;
- van Boxtel, Ruben;
- Clevers, Hans;
- Carvalho, Beatriz;
- Meijer, Gerrit A
Publication type:
Article
Obliteration of portal venules contributes to portal hypertension in biliary cirrhosis.
Published in:
Journal of Pathology, 2024, v. 263, n. 2, p. 178, doi. 10.1002/path.6273
By:
- Shan, Shan;
- Zhao, Xinyan;
- Wood‐Trageser, Michelle A;
- Hu, Doudou;
- Liu, Liwei;
- Qi, Beining;
- Jian, Jianbo;
- Wang, Ping;
- Lv, Wenjuan;
- Hu, Chunhong
Publication type:
Article
RAF1 gene fusions are recurrent driver events in infantile fibrosarcoma‐like mesenchymal tumors.
Published in:
Journal of Pathology, 2024, v. 263, n. 2, p. 166, doi. 10.1002/path.6272
By:
- Motta, Marialetizia;
- Barresi, Sabina;
- Pizzi, Simone;
- Bifano, Delfina;
- Lopez Marti, Jennifer;
- Garrido‐Pontnou, Marta;
- Flex, Elisabetta;
- Bruselles, Alessandro;
- Giovannoni, Isabella;
- Rotundo, Giovannina;
- Fragale, Alessandra;
- Tirelli, Valentina;
- Vallese, Silvia;
- Ciolfi, Andrea;
- Bisogno, Gianni;
- Alaggio, Rita;
- Tartaglia, Marco
Publication type:
Article
Research autopsy programmes in oncology: shared experience from 14 centres across the world.
Published in:
Journal of Pathology, 2024, v. 263, n. 2, p. 150, doi. 10.1002/path.6271
By:
- Geukens, Tatjana;
- Maetens, Marion;
- Hooper, Jody E;
- Oesterreich, Steffi;
- Lee, Adrian V;
- Miller, Lori;
- Atkinson, Jenny M;
- Rosenzweig, Margaret;
- Puhalla, Shannon;
- Thorne, Heather;
- Devereux, Lisa;
- Bowtell, David;
- Loi, Sherene;
- Bacon, Eliza R;
- Ihle, Kena;
- Song, Mihae;
- Rodriguez‐Rodriguez, Lorna;
- Welm, Alana L;
- Gauchay, Lisa;
- Murali, Rajmohan
Publication type:
Article
UPK3A+ umbrella cell damage mediated by TLR3–NR2F6 triggers programmed destruction of urothelium in Hunner‐type interstitial cystitis/painful bladder syndrome.
Published in:
Journal of Pathology, 2024, v. 263, n. 2, p. 203, doi. 10.1002/path.6275
By:
- Peng, Liao;
- Chen, Jia‐Wei;
- Chen, Yuan‐Zhuo;
- Zhang, Chi;
- Shen, Si‐Hong;
- Liu, Meng‐Zhu;
- Fan, Yang;
- Yang, Shi‐Qin;
- Zhang, Xiu‐Zhen;
- Wang, Wei;
- Gao, Xiao‐Shuai;
- Di, Xing‐Peng;
- Ma, Yu‐Cheng;
- Zeng, Xiao;
- Shen, Hong;
- Jin, Xi;
- Luo, De‐Yi
Publication type:
Article
Automated tumor immunophenotyping predicts clinical benefit from anti‐PD‐L1 immunotherapy.
Published in:
Journal of Pathology, 2024, v. 263, n. 2, p. 190, doi. 10.1002/path.6274
By:
- Li, Xiao;
- Eastham, Jeffrey;
- Giltnane, Jennifer M;
- Zou, Wei;
- Zijlstra, Andries;
- Tabatsky, Evgeniy;
- Banchereau, Romain;
- Chang, Ching‐Wei;
- Nabet, Barzin Y;
- Patil, Namrata S;
- Molinero, Luciana;
- Chui, Steve;
- Harryman, Maureen;
- Lau, Shari;
- Rangell, Linda;
- Waumans, Yannick;
- Kockx, Mark;
- Orlova, Darya;
- Koeppen, Hartmut
Publication type:
Article
TP53 disruptive mutation predicts platinum‐based chemotherapy and PD‐1/PD‐L1 blockade response in urothelial carcinoma.
Published in:
Journal of Pathology, 2024, v. 263, n. 2, p. 139, doi. 10.1002/path.6266
By:
- Jin, Kaifeng;
- Xu, Jingtong;
- Su, Xiaohe;
- Xu, Ziyue;
- Li, Bingyu;
- Liu, Ge;
- Liu, Hailong;
- Wang, Yiwei;
- Zhu, Yu;
- Xu, Le;
- Zhang, Weijuan;
- Liu, Zhaopei;
- Wang, Zewei;
- Chang, Yuan;
- Xu, Jiejie
Publication type:
Article
Patterns of structural variants within TP53 introns and relocation of the TP53 promoter: a commentary†.
Published in:
Journal of Pathology, 2024, v. 263, n. 2, p. 131, doi. 10.1002/path.6270
By:
- Beird, Hannah C;
- Lin, Dimitri;
- Lazar, Alexander J;
- Futreal, P Andrew
Publication type:
Article
Issue Information.
Published in:
Journal of Pathology, 2024, v. 263, n. 2, p. E1, doi. 10.1002/path.6184
Publication type:
Article

Works matching IS 00223417 AND DT 2024 AND VI 263 AND IP 2

From morphology to methylome: epigenetic studies of Müllerian mesonephric‐like adenocarcinoma reveal similarities to cervical mesonephric adenocarcinoma<sup>†</sup>.

Acquired NF2 mutation confers resistance to TRK inhibition in an ex vivoLMNA::NTRK1‐rearranged soft‐tissue sarcoma cell model.

Correction to 'Autophagy mediates survival of pancreatic tumour‐initiating cells in a hypoxic microenvironment'.

Co‐targeting BET, CBP, and p300 inhibits neuroendocrine signalling in androgen receptor‐null prostate cancer.

Cell division‐dependent dissemination following E‐cadherin loss underlies initiation of diffuse‐type gastric cancer.

Polyketide synthase positive Escherichia coli one‐time measurement in stool is not informative of colorectal cancer risk in a screening setting.

Obliteration of portal venules contributes to portal hypertension in biliary cirrhosis.

RAF1 gene fusions are recurrent driver events in infantile fibrosarcoma‐like mesenchymal tumors.

Research autopsy programmes in oncology: shared experience from 14 centres across the world.

UPK3A<sup>+</sup> umbrella cell damage mediated by TLR3–NR2F6 triggers programmed destruction of urothelium in Hunner‐type interstitial cystitis/painful bladder syndrome.

Automated tumor immunophenotyping predicts clinical benefit from anti‐PD‐L1 immunotherapy.

TP53 disruptive mutation predicts platinum‐based chemotherapy and PD‐1/PD‐L1 blockade response in urothelial carcinoma.

Patterns of structural variants within TP53 introns and relocation of the TP53 promoter: a commentary<sup>†</sup>.

Issue Information.